BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38001956)

  • 21. Relation between the renin-angiotensin-aldosterone system and left ventricular structure and function in young normotensive and mildly hypertensive subjects.
    Schlaich MP; Klingbeil A; Hilgers K; Schobel HP; Schmieder RE
    Am Heart J; 1999 Nov; 138(5 Pt 1):810-7. PubMed ID: 10539810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Corpus luteum number and the maternal renin-angiotensin-aldosterone system as determinants of utero-placental (vascular) development: the Rotterdam Periconceptional Cohort.
    Wiegel RE; Karsten MJH; Reijnders IF; van Rossem L; Willemsen SP; Mulders AGMGJ; Koning AHJ; Steegers EAP; Danser AHJ; Steegers-Theunissen RPM
    Reprod Biol Endocrinol; 2021 Nov; 19(1):164. PubMed ID: 34732224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aldosterone Levels, Aortic Stiffness, and Wave Reflection in Essential Hypertensive Patients.
    Tzamou V; Kyvelou SM; Karpanou E; Petras D; Vyssoulis G
    Am J Hypertens; 2015 Jul; 28(7):852-7. PubMed ID: 25542624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renin-angiotensin-aldosterone system in normal and hypertensive pregnancy. Response to postural stimuli.
    Fagundes VG; Lamas CC; Francischetti EA
    Hypertension; 1992 Feb; 19(2 Suppl):II74-8. PubMed ID: 1735598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in renin activity, aldosterone level and electrolytes in pregnancy-induced hypertension.
    Tsai YL; Wu SJ; Chen YM; Hsieh BS
    J Formos Med Assoc; 1993 Jun; 92(6):514-8. PubMed ID: 8106037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in the renin-angiotensin-aldosterone and kallikrein-kinin systems during normal and hypertensive pregnancy.
    Karlberg BE; Rydén G; Wichman K
    Acta Obstet Gynecol Scand Suppl; 1984; 118():17-24. PubMed ID: 6375241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes of dimeric inhibin B levels in maternal serum throughout healthy gestation and in women with gestational diseases.
    Petraglia F; Luisi S; Benedetto C; Zonca M; Florio P; Casarosa E; Volpe A; Bernasconi S; Genazzani AR
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2991-5. PubMed ID: 9284732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preeclampsia -- a state of prostaglandin deficiency? Urinary prostaglandin excretion, the renin-aldosterone system, and circulating catecholamines in preeclampsia.
    Pedersen EB; Christensen NJ; Christensen P; Johannesen P; Kornerup HJ; Kristensen S; Lauritsen JG; Leyssac PP; Rasmussen A; Wohlert M
    Hypertension; 1983; 5(1):105-11. PubMed ID: 6336717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Criteria for diagnosing primary aldosteronism on the basis of liquid chromatography-tandem mass spectrometry determinations of plasma aldosterone concentration.
    Baron S; Amar L; Faucon AL; Blanchard A; Baffalie L; Faucard C; Travers S; Pagny JY; Azizi M; Houillier P
    J Hypertens; 2018 Jul; 36(7):1592-1601. PubMed ID: 29677048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The renin-angiotensin-aldosterone system in pre-eclampsia: the delicate balance between good and bad.
    Verdonk K; Visser W; Van Den Meiracker AH; Danser AH
    Clin Sci (Lond); 2014 Apr; 126(8):537-44. PubMed ID: 24400721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renin-angiotensin-aldosterone system in pregnancy-induced hypertension.
    Israel A; Peceño A
    J Hum Hypertens; 2000 Apr; 14 Suppl 1():S36-9. PubMed ID: 10854079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First trimester uric acid and adverse pregnancy outcomes.
    Laughon SK; Catov J; Powers RW; Roberts JM; Gandley RE
    Am J Hypertens; 2011 Apr; 24(4):489-95. PubMed ID: 21252861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atrial natriuretic factor in pregnancy-induced hypertension and preeclampsia: increased plasma concentrations possibly explaining these hypovolemic states with paradoxical hyporeninism.
    Fievet P; Fournier A; de Bold A; el Esper N; Gregoire I; Westeel PF; Renaud H; Makdassi R
    Am J Hypertens; 1988 Jan; 1(1):16-21. PubMed ID: 2967079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renin-Angiotensin-Aldosterone System Triple-A Analysis for the Screening of Primary Aldosteronism.
    Burrello J; Buffolo F; Domenig O; Tetti M; Pecori A; Monticone S; Poglitsch M; Mulatero P
    Hypertension; 2020 Jan; 75(1):163-172. PubMed ID: 31760886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism.
    Seifarth C; Trenkel S; Schobel H; Hahn EG; Hensen J
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):457-65. PubMed ID: 12354127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First-trimester maternal renin-angiotensin-aldosterone system activation and fetal growth and birthweight: the Rotterdam Periconceptional Cohort.
    Wiegel RE; Aoulad Fares D; Willemsen SP; Steegers EAP; Danser AHJ; Steegers-Theunissen RPM
    Reprod Biomed Online; 2022 Jun; 44(6):1110-1122. PubMed ID: 35379566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral contraceptives--induced hypertension--nine years later.
    Laragh JH
    Am J Obstet Gynecol; 1976 Sep; 126(1):141-7. PubMed ID: 961741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renin Phenotypes Characterize Vascular Disease, Autonomous Aldosteronism, and Mineralocorticoid Receptor Activity.
    Hundemer GL; Baudrand R; Brown JM; Curhan G; Williams GH; Vaidya A
    J Clin Endocrinol Metab; 2017 Jun; 102(6):1835-1843. PubMed ID: 28323995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical implications of the ovarian/endometrial renin-angiotensin-aldosterone system.
    Hassan E; Creatsas G; Mastorakos G; Michalas S
    Ann N Y Acad Sci; 2000; 900():107-18. PubMed ID: 10818397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.